Generated by AI
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for serious hematologic diseases. The company’s work centers on red blood cell biology, with programs designed to address disorders involving heme biosynthesis and iron homeostasis. Its current pipeline includes therapies in development for rare blood diseases such as erythropoietic porphyrias, Diamond-Blackfan anemia, anemia associated with myelofibrosis, and polycythemia vera. Disc Medicine operates as a research-driven biotech business, advancing both clinical and preclinical candidates aimed at modifying fundamental biological pathways rather than offering broad commercial products. Headquartered in Watertown, Massachusetts, Disc Medicine plays a specialized role in the hematology market by concentrating on diseases with significant unmet medical need and limited treatment options.
Website321 Arsenal Street
Watertown, MA, 02472
United States
The latest articles about IRON.
Summary of Oct 21's posts. Generated by AI.
Summary of Oct 19's posts. Generated by AI.
Summary of Oct 20's posts. Generated by AI.
Investors talking about IRON also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.